AIDS-Associated Nephropathy is a kidney disease that can affect people with AIDS. It causes the kidneys to leak protein into the urine and can lead to kidney failure. It's a specific type of kidney damage linked to HIV infection.
Every report comes from a Lived member, sent anonymously.
Have you tried Highly Active Antiretroviral Therapy for HIV-Associated Kidney Disease?
HIV-associated nephropathy, often shortened to HIVAN, is a kidney disease caused by HIV itself. The virus infects cells inside the kidney's filters, which then become scarred and collapse. Healthy filters keep protein in the blood, so the first sign is usually a large amount of protein leaking into the urine. Kidney function can then fall quickly, sometimes over months, and without treatment HIVAN often leads to kidney failure. HIVAN occurs only in people living with HIV, and mostly when HIV has gone untreated for some time. It is one of several kidney problems people with HIV can develop. Others include kidney damage from diabetes or high blood pressure, immune reactions in the kidney, and side effects of some medicines. Since effective HIV treatment became widely available, HIVAN has become much less common, but it is still the most frequent kidney diagnosis in people with HIV who are not on treatment.
HIVAN develops when HIV is actively multiplying in the body, usually alongside advanced immune suppression, meaning a low CD4 count (the white blood cells that HIV destroys) and a high viral load (the amount of virus in the blood). It is often found when someone is first diagnosed with HIV or has been out of care. Genetics plays a large part. In the United States and Europe, HIVAN affects people of African ancestry almost exclusively. Much of that risk comes from variants in a gene called APOL1 that are common in people with West African ancestry. Carrying two of these variants greatly raises the chance of HIVAN in someone with uncontrolled HIV, but most people with the variants never develop kidney disease. Researchers think the immune response to HIV acts as a second trigger in people who are genetically susceptible. Family history of kidney failure also adds risk.
HIVAN often causes no symptoms at first, so it is usually found through routine tests. Guidelines recommend that people with HIV have a blood test of kidney function when HIV treatment starts or changes and at least twice a year after that, plus a urine test for protein at least yearly. The blood test gives an estimated glomerular filtration rate (eGFR), a measure of how well the kidneys filter blood. An eGFR of 60 or more is in the normal range, below 60 may mean kidney disease, and 15 or less means kidney failure. The urine test looks for albumin, a protein a healthy kidney holds back. HIVAN typically causes heavy protein loss, often at the level doctors call nephrotic range (more than about 3 grams a day), with a rapidly falling eGFR. Unlike many kidney diseases, it often does not cause much leg swelling or high blood pressure. An ultrasound often shows large, unusually bright kidneys. These clues point toward HIVAN but cannot confirm it, because other kidney diseases in people with HIV look similar and need different treatment. A kidney biopsy, in which a thin needle removes a small sample of kidney tissue for examination under a microscope, is needed to make the diagnosis. A kidney specialist (nephrologist) usually arranges it.
The most important treatment is effective HIV treatment, called antiretroviral therapy (ART). Guidelines recommend ART for anyone with confirmed or suspected HIVAN, whatever their CD4 count. Lowering the virus removes the main driver of kidney damage. In studies, people with HIVAN on ART kept working kidneys considerably longer and lived longer than those without it. These studies are observational, since withholding HIV treatment to run a trial would be unethical, and ART does not always reverse damage that has already happened. Some HIV medicines need dose changes when kidney function is reduced, so HIV and kidney clinicians often choose the regimen together. Blood pressure medicines called angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) are also recommended when they can be used safely. They reduce pressure inside the kidney's filters, which lowers protein leak and may slow the loss of function, even in people whose blood pressure is normal. They need periodic blood tests to check how the kidneys respond, and they are not used during pregnancy, so anyone who could become pregnant should discuss this with their prescriber. Steroids such as prednisone, which calm inflammation, are not used routinely. A doctor may consider them for an adult with biopsy-confirmed HIVAN whose kidney function keeps falling despite ART and an ACE inhibitor or ARB, weighing a possible benefit, shown only in small older studies, against the side effects of steroids. If the kidneys fail, both hemodialysis and peritoneal dialysis work for people with HIV, and dialysis centers need no special arrangements. Kidney transplant is also possible, and outcomes have improved substantially. Transplant centers generally require an undetectable viral load and a CD4 count above 200. Rejection is more common than in people without HIV, some HIV medicines interact strongly with anti-rejection drugs, and HIVAN can return in the new kidney, so the transplant and HIV teams work closely together.
The course of HIVAN depends heavily on how early it is found and how quickly HIV is brought under control. Without treatment, many people progress to kidney failure within about a year. With ART, median kidney survival in later studies was roughly three to four years, and some people keep stable function much longer. Kidney damage that is already advanced at diagnosis, such as a high creatinine level or very heavy protein loss, predicts a faster decline. Day to day, living with HIVAN usually means taking ART consistently, attending regular HIV and kidney appointments, and having blood and urine tests to track eGFR and protein. Many people need to avoid medicines that strain the kidneys, such as regular use of anti-inflammatory pain relievers like ibuprofen, and check with a clinician or pharmacist before starting new prescriptions or supplements. A kidney-friendly eating plan and blood pressure control may become part of care as function declines. If kidney failure is approaching, planning ahead matters. Choosing between dialysis types and starting transplant evaluation early gives more options. Preparing permanent dialysis access in advance avoids relying on temporary catheters, which carry a higher infection risk. Survival on dialysis has historically been lower for people with HIVAN than for other causes of kidney failure, which is one reason early detection and steady HIV treatment matter so much.
If you have HIV, ask for kidney blood and urine tests if they have not been done recently, especially if you are not yet on HIV treatment, have had a break in treatment, or have a family history of kidney failure. Ask about seeing a kidney specialist if your eGFR has dropped by more than a quarter to below 60, your urine shows a large amount of protein, or blood and protein appear in your urine together. Contact your care team promptly if you notice foamy urine, much less urine than usual, new swelling in your legs, feet or ankles, persistent nausea or loss of appetite, unusual tiredness, itching or muscle cramps, or new confusion or trouble concentrating. These can signal that kidney function is falling and treatment needs review.
Last reviewed • Oct 2026
Educational content, not medical advice.
Here you are I’m just saying hello to the community